Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Medtronic
Cerilliant
Chinese Patent Office
QuintilesIMS
Citi
Argus Health
Johnson and Johnson
Covington

Generated: December 11, 2018

DrugPatentWatch Database Preview

Litigation Details for International Automated Systems v. Digital Persona (D. Utah 2006)

« Back to Dashboard

International Automated Systems v. Digital Persona (D. Utah 2006)

Docket ➤ Try a Free Trial Date Filed 2006-01-24
Court District Court, D. Utah Date Terminated 2009-01-12
Cause 35:0271 Patent Infringement Assigned To Dee Vance Benson
Jury Demand Plaintiff Referred To
Parties DIGITAL PERSONA; IBM; IBM CORPORATION; IBM PERSONAL COMPUTING DIVISION; INTERNATIONAL AUTOMATED SYSTEMS; LENOVO (UNITED STATES); LENOVO GROUP; MICROSOFT; UPEK
Patents 10,046,056
Attorneys Bryan A. Kohm; Darryl M. Woo; Edwin H. Taylor; Gerald Chan; Heather N. Mewes; Isabella Fu; J. David Nelson; James G. Snell; James S. Jardine; Jared S. Goff; Jeffrey A. Miller; John D. Vandenberg; Joseph P. Barrett; Joseph R. Bond; Larry R. Laycock; Lester J. Vincent; Max D. Wheeler; Mitchell S. Feller; Morris Waisbrot; P. Matthew Cox; Richard S. Taffet; Rick B. Hoggard; Robert D. Dahle; Robyn L. Phillips; Ryan J. Marton; Samuel C. Straight; Stephanie S. Irvine; Sugithra Somasekar; Todd M. Shaughnessy; William Francis Haigney
Firms Barrett Law; Bingham McCutchen; Blakely Sokoloff Taylor & Zafman (Sunnyvale); Dickstein Shapiro LLP; Fenwick & West (Sf); Goff Patent Law; Hogan & Hartson, LLP-NY; Joseph R. Bond; Maschoff Brennan Pllc; Microsoft Corporation; Nelson Snuffer Dahle & Poulsen; Orrick Herrington & Sutcliffe (Menlo Park); Todd M. Shaughnessy; Vinson & Elkins LLP; Workman Nydegger
Link to Docket External link to docket
Biologic Drugs cited in International Automated Systems v. Digital Persona
The biologic drug covered by the patent cited in this case is ➤ Try a Free Trial .

Details for International Automated Systems v. Digital Persona (D. Utah 2006)

Date Filed Document No. Description Snippet Link To Document
2008-01-03 79 connect. Id. at 10:46-56. Moreover, the prosecution history of the ‘474 Patent supports the conclusion…licensee of U.S. Patent No. 5,598,474 (the “‘474 Patent” or the “Patent”), brought this patent infringement…perform the functions of the ‘474 Patent. Although one embodiment of the Patent can operate using a single …several directions.” ‘474 Patent at 7:9-10. This is the only algorithm the Patent clearly links to the function…See ‘474 Patent 1:33-35; 3:31-39; 4:32-51. Specifically, Column 10, lines 39-46 of the Patent states: External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
US Department of Justice
Colorcon
Federal Trade Commission
Harvard Business School
Moodys
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.